Answers are grounded in this paper and cite their sources.
I. Prange A, Wilson I, Breese G. et al: Hormonal alteration of imipramine response: a review. in Hormones, Behavior and Psychopathology. Edited by Sachar E. New York. Raven Press. 1976 2. Gram L: Plasma level monitoring of tricyclic antidepressant therapy. Clin Pharmacokinet 2:237-251. 1977 3. Brunswick DI, Needelman B. Mendels J: Radioimmunoassay of imipramine and desmethylimipramine. Life Sci 22:137-146, 1978 4. Burckhardt C, Raeder E. Muller V. et al: Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA 239:213-216, 1978 5. Hoffman I. Lowery R: The electrocardiogram in thyrotoxicosis. Am I Caldiob 6:893-904, 1960 6. Prange A: Paroxysmal auricular tachycardia apparently resulting from combined thyroid-imipramine treatment. Am I Psychiatry I 19:994-995, 1963 7. Zung WW: A self-rating depression scale. Arch Gen Psychiatry 12:63. 1965 8. Breese G, Traylor T. Prange A: The effect of triiodothyronine on the disposition and actions of imipramine. Psychopharmacologia 25:101-111. 1972 9. Prange A. Bakewell W: Effects of imipramine and reserpine on body size and organ size in euthyroid and hyperthyroid growing rats. I Pharmacol Exp Ther 15 1:409-412, 1966 10. Brodie B, Davies I, Hynie S. et al: Interrelationships of catecholamines with other endocrine systems.
No takes yet. Share an insight, caveat, or question.
Gold et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: